Diabetes Associated Ophthalmic Treatment Market Growth & Trends
The global diabetes associated ophthalmic treatment market size is expected to reach USD 51.33 billion by 2030, registering to grow at a CAGR of 6.9% from 2024 to 2030 . The increasing prevalence of type II diabetes, geriatric population, and availability of early detection techniques are some of the factors driving the growth. This is coupled with technological advancements and increasing awareness of early diagnostics to help increase the success rate of the available treatment options. An increasing number of clinical trials to assess new drugs and devices for the prevention and management of these ophthalmic conditions are expected to fuel market growth in upcoming years.
COVID-19 related diabetic and ophthalmic complications are expected to boost the market for diabetes associated ophthalmic treatment methods. COVID-19 has a long-term effect on diabetic conditions. This is expected to increase the demand for treatment procedures in upcoming years. An increasing number of initiatives being undertaken by governments and nonprofit organizations to increase diabetes associated ophthalmic disease awareness is expected to boost the adoption of devices used for the treatment. Furthermore, WHO and IDF are working together to prevent and control diabetes and ensure good quality of life for people worldwide by providing accessible treatment facilities.
Diabetes Associated Ophthalmic Treatment Market Report Highlights
- The diabetic retinopathy segment has captured the largest revenue share in 2023 followed by diabetic associated macular degeneration and glaucoma
- The drugs segment dominated the market and accounted for the highest revenue share in 2023 owing to factors such as the presence of major key players operating in the global market, high adoption rate, increased clinical trials to develop innovative drugs
- The hospitals segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in hospitals as compared to other healthcare facilities. An increasing number of hospital admissions of diabetes patients is boosting the demand for the segment, thereby propelling the growth
- North America held the largest revenue share in the market and is expected to maintain its dominance over the forecast period
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. The Diabetes Associated Ophthalmic Treatment Market Variables, Trends, & Scope
Chapter 4. Diabetes Associated Ophthalmic Treatment Market: Application Estimates & Trend Analysis
Chapter 5. Diabetes Associated Ophthalmic Treatment Market: Type Estimates & Trend Analysis
Chapter 6. Diabetes Associated Ophthalmic Treatment Market: End Use Estimates & Trend Analysis
Chapter 7. Diabetes Associated Ophthalmic Treatment Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Alcon
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- F. Hoffmann-La Roche Ltd
- Santen Pharmaceutical Co. Ltd.
- Novartis AG
- Pfizer, Inc.
- Genentech, Inc.
- Carl Zeiss Meditec
- Lumenis
- Ellex Medical Lasers Ltd.
- IRIDEX Corp.
- Topcon Corp.
- Abbott Medical Optics
- Quantel
- AbbVie Inc
- Bayer AG
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 32.41 Billion |
| Forecasted Market Value ( USD | $ 51.33 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
